Activation of human and mouse 2-5A synthetases and mouse protein P1 kinase by nucleic acids Structure-activity relationships and correlations with inhibition of protein synthesis and interferon induction by Torrence, Paul F. et al.
Volume 130, number 2 FEBS LETTERS August 1981 
ACTIVATION OF HUMAN AND MOUSE 2-5A SYNTHETASES AND MOUSE PROTEIN 
P, KINASE BY NUCLEIC ACIDS 
Structure-activity relationships and correlations with inhibition of protein synthesis and 
interferon induction 
Paul F. TORRENCE*, Margaret 1. JOHNSTON*, David A. EPSTEIN?, Helmut JACOBSEN? and 
Robert M. FRIEDMAN? 
*Laboratory of Chemistry and TLaboratory of Experimental Pathology, National Institute of Arthritis, Diabetes, and Digestive 
and Kidney Diseases, US National Institutes of Health, Bethesda, MD 2020.5, USA 
Received 16 June 1981 
1. Introduction 
The natural occurrence of fully double-stranded 
RNA (dsRNA) of high molecular weight in viruses, 
virus-like particles in fungi, as intermediates in the 
replication of RNA and DNA viruses has suggested 
some possible biological role for such molecules [ 11. 
Interest in dsRNA as a possible regulatory signal has 
been generated by the observations that dsRNA is a 
potent interferon inducer [2] and a powerful inhibitor 
Abbreviations: dsRNA, double-stranded RNA; 2-SA refers 
to a series of 2’,5’-oligoadenylates of general formula 
ppp(AP)nA where n has been reported to be between 1 and 
approximately 10; (I),, polyinosinsic acid; (C)n, polycytidylic 
acid; (A)n, polyadenylic acid, (U),, polyuridylic acid; (G),, 
polyguanylic acid; (m7G)n, poly(7-methylguanylic acid); 
(X),, polyxanthylic acid; (br’C)n, poly(5-bromocytidylic 
acid); poly(c’I), poly(74eazainosinic acids); (s’C),, poly- 
(2-thiocytidylic acid); (rT),, polyribothymidylic acid; (br’U)n, 
poly(5-bromouridylic acid); (f15U),, poly(5-fluorouridylic 
acid); (cl%)n, poly(5-chlorouridylic acid); poly(c7A), poly- 
(7deazaadenylic acid); (dUz)n, poly(2’-azido-2’deoxyuridylic 
acid); (dUfl),, poly(2’-fluoro-2’deoxyuridylic acid); (Am),, 
poly(2’0methyladenylic acid); (Urn),, poly(2’0methyl- 
uridylic acid); (Cm),, poly(2’-Q-methylcytidylic acid); 
(dA)n, polydeoxyadenylic acid; (dT),, polydeoxythymidylic 
acid; (dG)n, polydeoxyguanylic acid; (dC),, polydeoxycy- 
tidylic acid; (dI),, polydeoxyinosinic acid; (dAdT),, an 
alternating copolymer of deoxyadcnylic acid and deoxythy- 
midylic acids; (A-U),, an alternating copolymer of ribo- 
adenylic acid and ribouridylic acid; EMCV, encephalomy- 
ocarditis virus;Mp, molar concentration based on phosphate; 
protein P,, ribosomeassociated protein ofM, 65-67 000 
Elsevier/North-Holland Biomedical Press 
of protein synthesis in extracts of rabbit reticulocytes 
and of interferon-treated cells [3]. Particularly fasci- 
nating is the fact that interferon-pretreatment of cells 
gives cell-free extracts which have enhanced sensitivity 
to inhibition of translation by dsRNA [4]. Two sepa- 
rate pathways may mediate the protein synthesis 
inhibitory effects of dsRNA [5-71: the first pathway 
is referred to as the 2-SA pathway and involves the 
activation by dsRNA of an enzyme referred to 2-5A 
synthetase which synthesizes from ATP a mixture of 
2’,5’-linked oligonucleotides called 2-5A [8]. This 
oligonucleotide then activates a latent endonuclease 
which degrades mRNA and rRNA resulting in an 
inhibition of protein synthesis [5-71. A second distinct 
pathway is termed the protein kinase pathway. In this 
case, dsRNA activates a protein kinase which phos- 
phorylates a 65-67 K dalton protein (protein P,) and 
the small (a) subunit of eIF-2. In this case, phospho- 
rylation of eIF-2a is believed to decrease, either 
directly or indirectly, its ability to engage in initiation 
complex formation with a 40 S ribosomal subunit, GTP 
and Met-tRNA [3]. 
In this study, we report the relationships between 
the structure of a nucleic acid and its ability to activate 
the 2-5A synthetase and protein PI kinase. Since 
earlier studies have dealt with the dependence of inter- 
feron induction [2] and protein synthesis inhibition 
[9,10] on nucleic acid structure, it becomes possible 
to determine whether or not there may be any rela- 
tionships among these various biological activities of 
dsRNA. 
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Table 1 
August 1981 
Activation of L Cell 2-5A Synthetase and L Cell Protein P, Kinase by Polynucleotides 
- 
Polynucleotide 2-5A 
Synthetase 
activitya 
Protein P, kinaseb Polynucleotide 
Buffer 1 Buffer 2 
2-5A 
Synthetase 
activitya 
Protein P, kinaseb 
Buffer 1 Buffer 2 
single-strandedc <8 _ 
triple-stranded 
(A), .2(U), 
(AIn . W)n (0, 
(A), .2(I)n 
(A), CQ, . NJ), 
(A), + 2(X), 
<8 
<8 
<8 
<8 
<8 
t-k t 
i-t ND 
_ _ 
ND tt 
alternating copolymer 
(A-U), 2000 ND ND 
natural dsRNAs 
P. chrysogenum 
killer yeast 
f2 bacteriophage 
8000 
8000 
8000 
double-stranded 
double-sized dsRNAd 
I(12.5) C(13.2) 
I(8) C(8.3) 
I(2.5) C(3) 
I(12.5) C(3) 
I(2.5) C(13.2) 
2800 
2800 
2800 
2800 
2800 
(I), (C), and analogs 
(I), (C)n 
(11, . WC& 
(C’On (C)n 
(c’I), (br*C), 
(I), (S’C), 
8000e 
4000 
4000 
400 
120 
++ 
+t 
tt 
t+ 
tt 
+t 
+t 
++ 
+t 
t+ 
- 
tt 
_ 
it 
t+ 
+t 
+t 
t+ 
+t 
t+ 
+t 
t+ 
_ 
_ 
_ 
_ 
base-modified 
(X)n .(A), 
(X),,.(rT), 
(Xl,. WU& 
(c7Aln. WI, 
(c7A), . (rT), 
(c’A)~ . (br’U), 
(A), W), 
(A)n (fl’U)n 
(A), . WQ, 
(A),, . (brYJ), 
(A), KJ), 
sugar-modified 
(A), . WG,, 
(A),, (dUf-0, 
(A), Wm), 
MMn NJ), 
ChOn Wm), 
(I), . (Cm), 
@A), . @‘On 
(dG)n . (dC)n 
(dA-dT)n 
(W, (d0, 
(dI), (rC1, 
Win t W), 
Miscellaneous 
EMCV RNA 
globin mRNA 
Qp RNA 
MS-2 RNA 
R17 RNA 
<8 
<8 
<8 
280 
80 
80 
<8 
<8 
<8 
<8 
<8 
_ _ 
_ 
- 
- 
_ 
++ 
_ 
- 
- 
tt 
_ 
_ 
_ 
+t 
+ 
_ 
+ 
t+ 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
_ 
+ 
ND 
ND 
ND 
+ 
+ 
ND 
ND 
ND 
ND 
ND 
_ 
+ 
_ 
_ 
_ 
t 
ND 
ND 
_ 
_ 
_ 
_ 
<8 ND ND 
<8 ND ND 
800 ND ND 
12 ND ND 
20 ND ND 
a Results expressed as nmol 2-5A synthesized per liter per hour in a standard reaction mixture (100 ~1) [ 11,141 for mouse 
enzyme adsorbed to 2’,5’-ADP Sepharose. Each nucleic acid was evaluated at a final concentration of 2 X 10e4 Mp 
b Assaysed as described previously [ 15,16,23]. +t refers to intense phosphorylation of protein P, equal to that induced by (I), . 
(C),; t refers to definite phosphorylation compared to extracts containing no (I), . (C),, but less intense than that induced by 
(I), . (C), itself; alternatively, + implies that at a concentration of 2 X IO-’ M 
a phosphorylation of protein P, as did (I), (C), but did so less effectively at ower (I), . (C), concentrations (2 X 10m6 Mp, P 
the polynucleotide gave rise to just as intense 
2 X lo-‘M&. Buffer 1: 20 mM HEPES (pH 7.5), 10 mM KCl, 60 mM KOAc, 0.5 mM DTT, 25 mM Mg(OAc),. Buffer 2 (pro- 
tein synthesis buffer): 30 mM HEPES (pH 7.5) 110 mM KCl, 7 mM p-mercaptoethanol, 1 mM ATP, 0.1 mM CTP, 0.6 mM 
CTP, 10 mM creatine phosphate, 40 fiuM twenty amino acids minus leucine, 0.16 mg creatine kinase (163 units mg-I). Each 
polynucleotide was evaluated initially at 2 X 1 0m5 Mp 
’ Includes (A)n, (U),, (I),, CC),, (Xl,, (SW,, (br’C)n, (dUz), and (m’Qn 
d Samples of (I), (C) n were prepared by annealling (I), and (C), of varying molecular weights. The molecular size (in Svedberg 
units) of each individual strand is indicated in parentheses immediately after the abbreviation for the polynucleotide: thus, 
1(12.5)C(13.2) refers to dsRNA constituted from (I), of ~2~ w = 12.5 and (C), of s20 w = 13.2 S 
e range: 2000-10 000 
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2. Material and methods 
Cell-free extracts of interferon-treated or untreated 
mouse L cells and human Namalwa lymphoblastoid 
cells were prepared as described previously [9,11,12]. 
Sources and preparation of synthetic and naturally 
occurring polynucleotides were the same as outlined 
before [9,13]. Assays for the 2-5A synthetase and 
2-5A itself as well as the protein PI kinase have been 
detailed elsewhere [11,12,14-161. 
3. Results and discussion 
We have studied the nucleic acid activation of 
human or mouse 2-.5A synthetase under four separate 
assay conditions: (i) after adsorption to 2’,5’-ADP 
Sepharose; (ii) after adsorption to nucleic acids cova- 
lently linked to agarose; (iii) in solution under condi- 
tions of protein synthesis; and (iv) in solution under 
conditions idealized for activity of the human enzyme. 
The results of such experiments are presented in tables 
1 and 2. 
For evaluation of the ability of nucleic acids to 
activate the protein PI kinase, two assay systems were 
employed and both used extracts of interferon-treated 
mouse L cells (table 1). Since mouse L cells contain a 
phosphoprotein phosphatase activity which can be 
modified by nucleic acids as well as by the conditions 
of the assay [ 161, it is necessary to study the phospho- 
rylation of protein PI under both conditions idealized 
for kinase activity and under conditions of protein 
synthesis. 
The following conclusions can be drawn from the 
data of tables 1 and 2. 
(1) Activation of the 2-5A synthetase and protein 
PI kinase are dependent on the double-stranded nature 
of the nucleic acid. One apparent exception is Q/3 RNA 
which is nominally single-stranded, but activates the 
synthetase; however, Qfl RNA inhibits protein synthe- 
sis in reticulocyte lysates [ 171 and has been shown to 
contain up to 2% dsRNA [ 181. This may be associated 
with a minor component of Q/3 RNA which is or 
behaves like dsRNA [ 17,181. The fact that R17, MS2, 
globin and EMCV RNA do not activate the synthetase 
Table 2 
Activation of 2-5A Synthetase by Selected Polynucleotides Under Different Assay Conditions 
Polynucleotide L-cell enzymea Namalwa cell enzymeb 
Sepharose-boundc 
polynucleotide 
Protein synthesisd Solution assay 2’,5’-ADP-Sepharose- 
conditions 25 mM Mg2+ bound, 25 mM Mg’+ 
(I), . (C), 
(I), . WC), 
(I), . WC), 
(A), . W), 
I(12.5) . C(3)e 
I(2.5) . C(13.2) 
I(12.5) . C(13.2) 
I(2.5) . C(3) 
2500 
2500 
<40 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
<<4 
40 000 
20 
40 000 
20 
33 
0.33 
0.44 
6.6 
ND 
ND 
ND 
ND 
2 
0.14 
ND 
0.02 
ND 
ND 
ND 
ND 
a The formation of 2-5A is given as nmol 1-l h-’ in a standard reaction mixture 
b The formation of 2-5A is given as nmol mg-’ protein h-’ in a reaction mixture of 100 ~1 volume 
c (C),, @r5CJn, or (s’C), was annealled to AGp0ly(1)~~ (PL Biochemicals) in Tris-buffered saline and 
then 100 ~1 of cell sap from interferon-treated cells was adsorbed to the thoroughly washed resin for a 
periods of 12-16 h, after which the resin was exhaustively washed with buffer and further processed as 
described for 2’,5’-ADP-Sepharose-bound enzyme [ 11,141 
d Conditions were identical to these described for protein synthesis in [9], except that interferon-treated 
L cell SlOs had not been treated with micrococcal nuclease or preincubated 
e These differently sized preparations of (I), . (C), were constituted from homopolymers of varying 
molecular size (see table 1) 
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Table 3 
Comparative Potencies of Various RNAs for the Activation 
of Mouse L Cell 2-5A Synthetase Adsorbed to 2’,5’-ADP 
Sepharose 
Polynucleotide M acta 
P. c/zr>~sogenum dsRNA 
bacteriophage dsRNA 
killer yeast dsRNA 
(I), (C), 
(c’& (0, 
(11, WC), 
(c?), (brsC)n 
bacteriophage QP RNA 
a Represents a comparison of the ability to various nucleic 
acids to activate the synthetase and is defined as the molar 
concentration of RNA required to produce sufficient 2-5A 
to effect, after a 10 OOO-fold dilution, a 33% reduction in 
EMCV RNA-stimulated protein synthesis in cell free extracts 
of interferon-treated mouse L cells. The smaller the Mact, 
the more potent the nucleic acid as a synthetase activator 
even at quite high concentrations suggests either that 
the short dsRNA hairpin structures occurring in the 
secondary structure of these RNAs cannot activate 
the synthetase because they are too short or that they 
may not be conveniently accessible to the synthetase. 
The alternating copolymer (A- U), leads to substantial 
2-5A synthesis, implying that a hairpin structure of 
sufficient length is capable of activating the synthetase. 
(2) The presence of a 2’-hydroxyl group in both 
strands of the nucleic acid seems critical to its ability 
to activate 2--5A synthetase. The presence of a 
2’-hydroxyl group is not absolutely required for acti- 
vation of the protein Pr kinase since (A), . (dUfl)n 
and (I), . (Cm), could both activate the kinase, albeit 
not as well as (I), (C), itself. 
(3) Although quite a number of nucleic acids viz., 
[(I), (C),, (A-U),, P. chrysogenum dsRNA, killer 
yeast dsRNA, f2 bacteriophage dsRNA, (I), . (br’C),, 
(~‘~1)~ . (C)n,(C71). (brSC)n,(I)n . (s"C),,(A), . (U>,, 
(c7A), . (U),, (c7A), . (r’f), and (c7A), . (brSU)n] 
are capable of activating the 225A synthetase, only a 
few are comparable in potency to (I), . (C), (tables 1 
and 3). 
(4) When synthetase activity is analyzed under con- 
siderably different assay conditions (table 2) the fol- 
lowing points emerge: 
(i) Under all conditions, (I), . (C), is the most potent 
activator (with the possible exception of the natural 
dsRNAs). 
(ii) men analyzed by adsorption of Namalwa enzyme 
to 2’,5’-ADP Sepharose, (I), (brsC), is a more potent 
synthetase activator than is (A), . (U),; however, 
when the assay is conducted in solution at high Mg”+ 
concentration, (A), . (U), is a more potent activator 
than is (I), (b?(Y),. In other words, high Mg*+ con- 
centrations dramatically increase the potency of 
(A), (U), as a synthetase activator but does not affect 
substantially the relative potency of other activators. 
Previous studies have probed the possible relation- 
ship between inhibition of protein synthesis by dsRNA 
in extracts of interferon-treated cells or rabbit reticu- 
locyte lysates and interferon induction by dsRNA 
[9,10]. These studies concluded that, although there 
existed definite similarities in the structural features 
required for interferon induction and for protein syn- 
thesis inhibition, there were sufficient exceptions to 
deny any simple relationship. Studies with the enzyme 
systems that presumably lead to protein synthesis 
inhibition by dsRNA, namely, the 225A synthetase 
and the protein Pr kinase, have concluded that the 
similarity in certain requirements of molecular size 
and presence of 2’-hydroxyl groups suggest a relation- 
ship between synthetase activation and interferon 
induction [ 19,211. The data presented in this paper 
suggest hat there may be no simple relationship 
between interferon induction by polynucleotides and 
activation of either ‘2-5A synthetase or the protein Pr 
kinase. 
The polynucleotide (I), (C),. (I), . (br’C),> 
(A), (rT),, (A), . (U)n, (c71)n . (C)n, (c71)n . (brsC),, 
f’. chrysogenur?z dsRNA, f2 bacteriophage dsRNA, 
killer yeast dsRNA, (A-U), and (I), (s*C), are all 
good inducers of interferon in various cell cultures and 
in animals [2,13]; however, (A), (rT), does not 
activate 2-5A synthetase at all, and (A), . (U), and 
(I), (s2C), are very poor activators. Conversely, 
(c7A), . (U),, (c7A), . (rT), and (c7A), . (brsU)n 
are not active as interferon inducers 12 J but do activate 
the synthetase, albeit rather ineffectively. In addition, 
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(dlz),, .(C)n > a 2’-modified polymer which induces 
interferon [2 11, is inactive as an activator of synthetase 
(P. F. Torrence, E. De Clercq and M. Ikehara, unpub- 
lished observations). Thus, no direct relationship 
between interferon induction and 2-5A synthetase 
activation can be implied. 
It is also unlikely that any direct relationship exists 
between interferon induction and activation of the 
protein Pr kinase for the following reasons: 
(i) Three triple-helical nucleic acids, inactive as 
interferon-inducers, are good activators of the kinase. 
(ii) The polynucleotides, (I), . (s’(Z), and (c71), 
(C)n, which are good interferon inducers, do not 
activate the kinase. 
(iii) The 2’-modified polymers, (A), . (dUfl), and 
(I), . Q-4, j which do not induce interferon, are 
activators of the protein Pr kinase. 
The data of table 2 illustrate the complexity of the 
2-5A synthetase and sound a note of caution regarding 
general conclusions about the relationship of the 2-SA 
synthetase to various biological activities of dsRNAs. 
Depending on the nature of the enzyme, the concen- 
tration of divalent cations and whether the enzyme 
is bound to a matrix or free in solution, nucleic acids 
may be relatively active or inactive as activators; in 
addition, their relative potencies as activators may vary. 
Perhaps at least a part of this variation may be linked 
to the phosphodiesterase activity which degrades 
2-5A [22]. 
A final point pertains to the relationship between 
inhibition of translation by dsRNA and the two dsRNA- 
dependent enzyme systems, the protein Pr kinase and 
the 2%5A synthetase, believed to be responsible for 
mediating the effect of dsRNA. The triplexes 
(A), . (U>, 0% and (A), . (U), . (I), are effective 
inhibitors of protein synthesis in extracts of interferon- 
treated cells [9] and good activators of the protein Pr 
kinase (table l), but do not activate the 2-5A syn- 
thetase; in addition, (A), . (U), is a relatively poor 
activator of synthetase under most conditions (tables 
1 and 2), but is quite effective as an activator of kinase 
and as an inhibitor of translation. The duplex, 
(I), . (s2C),, is a very poor synthetase activator and 
is inactive as a kinase activator; perhaps as a result it 
is also inactive as an inhibitor of protein synthesis. 
(l), (C)r, is a potent activator of both kinase and 
synthetase, but recent evidence suggests that in extracts 
of interferon-treated L cells, the 2-5A system is 
primarily responsible for inhibition of translation [23]. 
Taken together, these data suggest hat different 
nucleic acids or different dsRNAs might inhibit protein 
synthesis by different mechanisms. 
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